Heavier and taller children more likely to develop kidney cancer as adults
A recent study from Denmark presented at this year's European [...]
Immunotherapy for genitourinary cancer in the elderly
In the following interview, Dr Bradley McGregor, a medical oncologist [...]
Assessment of concomitant medication for kidney cancer
A recent study, published in the Journal of Cancer Research [...]
New drug combination for advanced kidney cancer
Scientists have identified a promising new drug for renal cell [...]
Potential prognostic biomarker for clear cell RCC
A recent study published in Oncology Letters last month has [...]
Targeted therapies with immunotherapies in kidney cancer
The following video is an interview with Professor Thomas Powles [...]
Pembrolizumab plus axitinib granted FDA approval for advanced kidney cancer
The Food and Drug Administration (FDA) in the United States [...]
Dalantercept plus axitinib combination for advanced kidney cancer
The results from a recent phase II study comparing a [...]
Patients may not be able to tolerate recommended dose of cabozantinib
A recent study published on Oncology this month suggests that [...]
First immunotherapy combination of ipilimumab plus nivolumab available to patients in England
We are very pleased to learn that the ipilimumab plus [...]
